In its early stages,
kidney cancer typically has no symptoms.
Not exact matches
Half of the patients treated in this study responded to either ponatinib (
typically used for certain types of leukemia) or pazopinib (a
kidney cancer drug), depending on the genetic alterations identified through sequencing.
The drugs used, pazopanib (top) and ponatinib, are
typically used to treat
kidney cancer and certain types of leukemia, respectively.
Health problems like arthritis, hormonal diseases,
cancers, and
kidney or liver diseases
typically have a slow onset.
These
typically will include
cancer, stroke, heart attack, and
kidney failure.